INMUNE BIO INC. Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net
INMUNE BIO INC. (INMB) had Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net of $45.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Notes › Debt
us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet · last filed 2024-05-09
- 2024-03-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $45.00K.
- 2023-12-31: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $79.00K; Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net as first filed $236.00K.
- 2023-09-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $124.00K.
- 2023-06-30: Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net $178.00K.
| Period end | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net as first filed |
|---|---|---|
| 2024-03-31 | $45.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $79.00K 10-K · filed 2024-03-28 | $236.00K 10-Q · filed 2023-05-03 |
| 2023-09-30 | $124.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $178.00K 10-Q · filed 2023-08-07 | |
| 2022-12-31 | $303.00K 10-K · filed 2023-03-02 | |
| 2022-09-30 | $371.00K 10-Q · filed 2022-11-02 | |
| 2022-06-30 | $429.00K 10-Q · filed 2022-08-03 | |
| 2022-03-31 | $486.00K 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $542.00K 10-K · filed 2022-03-03 | |
| 2021-09-30 | $599.00K 10-Q · filed 2021-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |